Zacks Investment ResearchTue, 12 May 2026 16:51:06 GMTHalozyme's Q1 Earnings & Revenues Beat Estimates, Stock UpHALO-0.67%
Seeking AlphaTue, 12 May 2026 02:50:43 GMTHalozyme Therapeutics, Inc. (HALO) Q1 2026 Earnings Call TranscriptHALO-0.67%
Zacks Investment ResearchMon, 11 May 2026 22:31:06 GMTHalozyme Therapeutics (HALO) Reports Q1 Earnings: What Key Metrics Have to SayHALO-0.67%
Zacks Investment ResearchMon, 11 May 2026 22:16:09 GMTHalozyme Therapeutics (HALO) Surpasses Q1 Earnings and Revenue EstimatesHALO-0.67%
Zacks Investment ResearchWed, 06 May 2026 14:15:42 GMTHalozyme Therapeutics (HALO) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance MeasuresHALO-0.67%
Seeking AlphaWed, 06 May 2026 04:54:38 GMTHalozyme Therapeutics: The Royalty Engine Is Becoming A Drug-Delivery Toll RoadHALO-0.67%
Zacks Investment ResearchTue, 28 Apr 2026 15:08:15 GMTHalozyme Therapeutics (HALO) Earnings Expected to Grow: What to Know Ahead of Q1 ReleaseHALO-0.67%
Zacks Investment ResearchThu, 19 Mar 2026 16:31:22 GMTWhy Is Halozyme Therapeutics (HALO) Down 13.1% Since Last Earnings Report?HALO-0.67%
Seeking AlphaWed, 11 Mar 2026 17:22:18 GMTHalozyme Therapeutics, Inc. (HALO) Presents at The Citizens Life Sciences Conference 2026 TranscriptHALO-0.67%
Seeking AlphaTue, 10 Mar 2026 19:00:19 GMTHalozyme Therapeutics, Inc. (HALO) Presents at Leerink Global Healthcare Conference 2026 TranscriptHALO-0.67%
Seeking AlphaWed, 04 Mar 2026 01:52:13 GMTHalozyme Therapeutics, Inc. (HALO) Presents at TD Cowen 46th Annual Health Care Conference TranscriptHALO-0.67%
FXEmpireFri, 29 Aug 2025 18:01:15 GMTIdentify Superstar Stocks Like Halozyme with Money FlowsHALO-0.67%
FXEmpireFri, 23 May 2025 10:30:33 GMTOversold Opportunities in Mid-Cap StocksHALO-0.67%SPX+0.17%TW-0.96%
